Articles

The new manufacturing company has been launched under the Defense Production Act to produce APIs in the US.  

Kodak Launches Kodak Pharmaceuticals

The company has begun development of a 3D bioreactor for the cGMP production of extracellular vesicle exosomes.

Rigenerand Develops 3D Bioreactor for Extracellular Vesicle Exosomes Production

Vico Therapeutics has raised $31 million (€27 million) in a Series A financing round, which the company will use to further advance its Antisense OligoNucleotides lead platform.

Vico Therapeutics Raises $31 Million in Series A Financing Round

PCI Pharma has announced the creation of a new clinical center of excellence in Western Europe at its site in Berlin, Germany.

PCI Pharma Expands Clinical Trial Services

EMA has started a review of dexamethasone as a treatment for adults with COVID-19 who require respiratory support and have been admitted to hospital.

EMA Starts Review of Dexamethasone as COVID-19 Treatment

EMA's CHMP has adopted a positive opinion for Dapivirine Vaginal Ring for women in non-EU countries where HIV disease burden is high.

CHMP Adopts Positive Opinion for Dapivirine Vaginal Ring

Pharmapack Europe 2021 has been rescheduled after a careful review by the event organizers with key stakeholders.

Pharmapack Organizers Announce 2021 Event to Move from January to May

Avacta Group has expanded its partnership with Daewoong Pharmaceutical to include Affimer molecules that target viruses, such as coronavirus.

Avacta, Daewoong Pharmaceutical Expand Collaboration to Include COVID-19 Therapy

The transaction is expected to be completed during the fourth quarter of 2020. 

Cerevel Therapeutics Enters into $445 Million Deal with Arya Sciences

Sangamo will receive a $75 million upfront license fee payment and will be eligible to earn up to $720 million in other development and commercial milestone payments, including up to $420 million in development milestones and up to $300 million in commercial milestones. 

News